What's TTS, rare condition caused by AstraZeneca's Covishield vaccine?
Image Credit: newsbytes
In a significant development, AstraZeneca, the manufacturer of the Covishield vaccine, has acknowledged in legal documents that its vaccine may trigger a rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS). The company is currently facing a class action lawsuit over claims that its vaccine can cause TTS, an infrequent condition characterized by blood clot formation and a decrease in blood platelets.